Find below a list of trials iRehab can co-enrol with.

These trials have been considered by their respective trial management groups and Chief Investigators. This process has taken into consideration any potential issues regarding study design and statistical considerations; biological and scientific considerations; implications of co-enrolment on participants and their relatives; legal and ethical issues; logical and organisational considerations.

Approved co-enrolling trials:

• A2BLink opens in a new window
• ABC post ICULink opens in a new window
• ADAPT-SepsisLink opens in a new window
• AIRWAYS-3Link opens in a new window
• ASPECTLink opens in a new window
• A-STOPLink opens in a new window
• ED-POC
• EXTENDLink opens in a new window
• FLAIR
• FLO-ELALink opens in a new window
• GenOMICCLink opens in a new window
• GuARDS
• Hypersensitivity
• InCyst Study
• MARCHLink opens in a new window
• MaST
• mecROXLink opens in a new window
• MOSAICCLink opens in a new window
• NCARCLink opens in a new window
• PHINDLink opens in a new window
• PQIPLink opens in a new window
• PREFIBRILLATE
• PRONTO
• PROVE
• REALISTLink opens in a new window
• RecoveryLink opens in a new window
• REMAP-CAPLink opens in a new window
• RESULT-HIP
• SOSLink opens in a new window
• SRAVILink opens in a new window
• SWiFT
• T4PLink opens in a new window
• TILIA
• UK-ROXLink opens in a new window including EXAKT sub-studyLink opens in a new window
• Vital
• VITDALIZE UKLink opens in a new window

New trials will be added in due course following discussions with the respective trial management groups and Chief Investigators. If you have any further queries or wish to discuss additional trials, please contact the iRehab trial team.

Enquiries:

Please direct all enquiries to the iRehab team;

Kerry Raynes: Trial Manager

Louisa Edwards, Trial Coordinator

Katherine Jones, Research Fellow

Email: iRehab@warwick.ac.uk

Tel: 02476151367